There is 1 version of this bill. View text

Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries

Titles (2)

Short Titles

Short Titles - House of Representatives

Short Titles as Introduced

Strategies to Address Antimicrobial Resistance Act

Official Titles

Official Titles - House of Representatives

Official Title as Introduced

To amend the Public Health Service Act to address antimicrobial resistance.

Actions Overview (1)

Date Actions Overview
09/27/2007Introduced in House

All Actions (3)

Date All Actions
11/08/2007Referred to the Subcommittee on Health.
Action By: Committee on Energy and Commerce
09/27/2007Referred to the House Committee on Energy and Commerce.
Action By: House of Representatives
09/27/2007Introduced in House
Action By: House of Representatives

Cosponsors (28)

Committees (1)

Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.

Committee / Subcommittee Date Activity Reports
House Energy and Commerce09/27/2007 Referred to
House Energy and Commerce Subcommittee on Health11/08/2007 Referred to

A related bill may be a companion measure, an identical bill, a procedurally-related measure, or one with text similarities. Bill relationships are identified by the House, the Senate, or CRS, and refer only to same-congress measures.

Latest Summary (1)

There is one summary for H.R.3697. View summaries

Shown Here:
Introduced in House (09/27/2007)

Strategies to Address Antimicrobial Resistance Act - Amends the Public Health Service Act to direct the Secretary of Health and Human Services to: (1) establish, and appoint the Director of, the Office of Antimicrobial Resistance in the Office of the Assistant Secretary for Health to develop plans for addressing antimicrobial resistance in the United States and internationally; (2) establish the Public Health Antimicrobial Advisory Board to assist the Director; and (3) develop an antimicrobial resistance strategic research plan. Renews the Antimicrobial Resistance Task Force and sets forth its membership and duties.

Requires sponsors of human and animal antimicrobial drug products to report to the Office of Antimicrobial Resistance the amount of such drug products sold or distributed in the United States in a calendar year. Requires the Director to make summaries of drug distribution data publicly available.

Requires the Secretary to: (1) establish at least 10 Antimicrobial Resistance Clinical Research and Public Health Network sites to describe outbreaks of antimicrobial resistant pathogens and monitor the patterns of such pathogens in individuals; and (2) award competitive grants to establish demonstration projects to assess the scope of the antimicrobial resistance problem and the use of antimicrobial drugs.

Requires the Comptroller General to report to Congress on the effectiveness of this Act.